reglab/statecodes huggingface dataset:
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 1 - Hereditary and Congenital Disorders Programs › Section 13-113 - Newborn Screening Program Fund

(a)    In this section, “Fund” means the Newborn Screening Program Fund.
(b)    There is a Newborn Screening Program Fund.
(c)    The purpose of the Fund is to provide funding for the screening of newborn infants in the State for certain hereditary and congenital disorders.
(d)    The Secretary shall administer the Fund.
(e)    (1)    The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(2)    The State Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(f)    The Fund consists of:
(1)    Revenue distributed to the Fund under § 13–111(f) of this subtitle;
(2)    Money appropriated in the State budget to the Fund;
(3)    Interest earnings of the Fund; and
(4)    Any other money from any other source accepted for the benefit of the Fund.
(g)    The Fund may be used only to cover the administrative, laboratory, and follow–up costs associated with the performance of newborn screening tests conducted under this subtitle.
(h)    (1)    The State Treasurer shall invest the money of the Fund in the same manner as other State money may be invested.
(2)    Any interest earnings of the Fund shall be credited to the Fund.
(i)    Expenditures from the Fund may be made only in accordance with the State budget.
(j)    The accounts and transactions of the Fund shall be subject to audit by the legislative auditor as provided in § 2–1220 of the State Government Article.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 2 - State Advisory Council on Health and Wellness › Section 13-204 - General Consideration

(a)    A member of the Advisory Council:
(1)    May not receive compensation; but
(2)    Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(b)    (1)    The Advisory Council shall create committees as it determines to organize its work, including at a minimum the following four committees:
(i)    Arthritis;
(ii)    Diabetes;
(iii)    Heart Disease and Stroke; and
(iv)    Physical Fitness.
(2)    Each Advisory Council member shall serve on at least one committee.
(c)    The Secretary shall designate the staff necessary to carry out this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 2 - State Advisory Council on Health and Wellness › Section 13-205 - Duties of Council

The Advisory Council shall:
(1)    Promote evidence–based programs for healthy lifestyles and the prevention, early detection, and treatment of chronic disease; and
(2)    Make recommendations to the Department related to chronic disease prevention, health, and wellness.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-302 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Commission” means the State Commission on Kidney Disease.
(c)    “Department” means the department responsible for administering the Kidney Disease Program.
(d)    (1)    “Liquid assets” includes cash, bank accounts, and investments such as stocks and bonds that can be readily converted to cash.
(2)    “Liquid assets” does not include an individual’s:
(i)    Principal residence; or
(ii)    Principal car.
(e)    “Program” means the Kidney Disease Program.
(f)    “Recipient” means an individual with chronic kidney disease who has been certified to receive benefits under the Kidney Disease Program.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-303 - Findings; Responsibilities of State

(a)    The General Assembly finds that:
(1)    One of the most serious and tragic problems facing the public health and welfare is the death of hundreds of people in this State each year from chronic kidney disease, when the present state of medical art and technology could return these individuals to a socially productive life;
(2)    Advances and discoveries in the treatment of patients who have chronic kidney disease allow not mere survival, but rehabilitation to normal occupations and activities;
(3)    Treatment for persons with kidney disease is very expensive and continues throughout a person’s life;
(4)    Private insurance coverage for kidney disease treatment is difficult to obtain; and
(5)    Individuals who receive State benefits for kidney disease treatment should be responsible for bearing some of the cost of that care taking into account their ability to pay.
(b)    (1)    This State recognizes its responsibilities:
(i)    To allow its citizens to keep their health without being made paupers; and
(ii)    To use its resources and organization to aid in gathering and giving out information on the treatment of chronic kidney disease.
(2)    The General Assembly seeks to meet these responsibilities by making the treatment of chronic kidney disease easily available through the education, treatment, and reimbursement programs under this subtitle, thus, lowering the cost of this treatment.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-305 - Commission -- Membership

(a)    (1)    The Commission consists of 12 members appointed by the Governor.
(2)    Of the 12 Commission members:
(i)    1 shall be an individual from the Renal Administrators Association;
(ii)    3 shall be individuals who are laypersons to the field of medicine;
(iii)    3 shall be individuals appointed at the discretion of the Governor who:
1.    Are medical specialists or other patient care providers in nephrology or kidney transplants; and
2.    Do not have direct ownership of more than 30% in renal dialysis or kidney transplant centers that do business in the State;
(iv)    4 shall be individuals appointed as provided in paragraph (3) of this subsection; and
(v)    1 shall be a renal social worker nominated by the Maryland Chapter of the Council of Nephrology Social Workers or the National Capital Area Chapter of the Council of Nephrology Social Workers.
(3)    (i)    Except as provided in subparagraph (iv) of this paragraph, the Governor shall appoint 1 member from a list of individuals submitted to the Governor by each of the following organizations:
1.    The Kidney Foundation of Maryland;
2.    The faculty of the University of Maryland School of Medicine;
3.    The faculty of the Johns Hopkins University School of Medicine; and
4.    The Medical and Chirurgical Faculty of the State of Maryland.
(ii)    The number of names on a list shall be at least 2.
(iii)    An organization shall submit its list at least 3 months before the expiration of the term of the member who represents the organization.
(iv)    If a list is not submitted to the Governor as required under subparagraph (iii) of this paragraph or if a vacancy occurs for a reason other than expiration of the term, the Governor may appoint any individual without the list.
(b)    (1)    The term of a member is 4 years.
(2)    The terms of the members are staggered as required by the terms provided for members of the Commission on July 1, 1982. The terms of one fourth of those members end each year.
(3)    At the end of a term, a member continues to serve until a successor is appointed and qualifies.
(4)    A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
(5)    A member who serves 2 consecutive full 4–year terms may not be reappointed for 4 years after completion of those terms.
(6)    (i)    If a vacancy occurs, the Governor promptly shall appoint a successor who will serve until the term expires.
(ii)    The successor may be reappointed for a full term.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-306 - Commission -- Quorum; Meetings; Compensation; Staff

(a)    The members present at a meeting are a quorum to do business.
(b)    The Commission shall meet at least twice a year, at the times and places that it determines.
(c)    A member of the Commission:
(1)    May not receive compensation; but
(2)    Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(d)    The Secretary shall designate the staff necessary to carry out this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-307 - Commission -- Miscellaneous Powers and Duties

(a)    The Commission:
(1)    Shall institute and supervise education programs for health providers and the public on the prevention and treatment of chronic kidney disease; and
(2)    May use existing programs and groups for this purpose.
(b)    The Commission shall:
(1)    Evaluate annually the Kidney Disease Program under this subtitle; and
(2)    Submit an annual report of the evaluation to the Governor.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-308 - Rules, Regulations, and Standards

(a)    Subject to the limitations provided in this section, the Commission may adopt rules and regulations to carry out the provisions of this subtitle.
(b)    The Commission shall adopt physical and medical standards for the operation of dialysis and transplant centers.
(c)    (1)    The Commission shall adopt reasonable medical standards for acceptance of an individual for treatment.
(2)    The Commission may not adopt any standard that prevents an individual from receiving federal medical or financial aid.
(d)    The Commission may adopt rules and regulations for:
(1)    Coverage of treatment that is given outside this State; and
(2)    Approval or disapproval, for purposes of State payment under this subtitle, of a dialysis or transplant center that is outside this State.
(e)    The Department, in consultation with the Commission, shall adopt rules and regulations under this subtitle governing:
(1)    Nonmedical eligibility criteria for recipients; and
(2)    Reimbursement of providers and recovery of Program expenditures from recipients and third parties.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-309 - Duties of Secretary

The Secretary:
(1)    Is responsible for the operation of the Kidney Disease Program under this subtitle within the rules, regulations, and standards that the Commission and the Department adopt;
(2)    Shall disburse and collect any funds under this subtitle; and
(3)    Shall keep the Commission informed of:
(i)    The progress of the Kidney Disease Program; and
(ii)    Any need for a change in its rules, regulations, or standards.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-310.1 - Kidney Disease Fund

(a)    In this section, “Fund” means the Kidney Disease Fund.
(b)    There is a Kidney Disease Fund.
(c)    (1)    Subject to the provisions of paragraphs (2) and (3) of this subsection, the Commission shall set by regulation reasonable fees to be paid by all certified kidney dialysis and transplant centers as an additional requirement for annual certification.
(2)    The provisions of this section do not apply to:
(i)    State-owned facilities; or
(ii)    Hospital services under the jurisdiction of the Health Services Cost Review Commission.
(3)    The fee set by the Commission may not exceed $1500 per year.
(d)    The Department shall collect the fee set by the Commission under subsection (c) of this section and transfer the fee into the Fund.
(e)    (1)    The Fund is a continuing, nonlapsing fund, not subject to § 7-302 of the State Finance and Procurement Article.
(2)    (i)    The Fund shall be used exclusively to offset and partially cover the actual documented direct costs of fulfilling the statutory and regulatory duties of the Commission as described in this subtitle.
(ii)    The Department shall pay the indirect costs the Commission incurs in fulfilling the statutory and regulatory duties of the Commission as described in this subtitle.
(3)    Any unspent portions of the Fund may not be transferred or revert to the General Fund of the State, but shall remain in the Fund to be used for the purposes specified in paragraph (2)(i) of this subsection.
(f)    (1)    The Chairman of the Commission or the designee of the Chairman shall administer the Fund.
(2)    Moneys in the Fund may be expended only for the purposes specified in subsection (e)(2)(i) of this section.
(g)    The Legislative Auditor shall audit the accounts and transactions of the Fund as provided in § 2-1220 of the State Government Article.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-311 - Certification of Eligibility

(a)    The Department shall certify an individual as eligible for benefits under the Program if the Department determines that:
(1)    The individual has chronic kidney disease as defined in the Commission’s regulations; and
(2)    The individual meets the residency, citizenship, and other nonmedical eligibility requirements established by the Department.
(b)    (1)    The certification of an individual under this section shall be for a period of 1 year.
(2)    The certification is renewable after each 1-year period if the individual meets the requirements of subsection (a) of this section.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-312 - Application for Financial Assistance

(a)    Except as provided in subsection (b) of this section, the Department shall require Program recipients to apply for eligibility in the Maryland Medical Assistance Program, the Medicare Part B Program, and the Medicare Part D Program within 60 days of notification to do so by the Department.
(b)    The Department may not require Program recipients to apply for eligibility in the Medicare Part B Program or the Medicare Part D Program if the Department determines the Program recipient has comparable insurance coverage.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-313 - Annual Fee

(a)    (1)    Prior to receiving Program benefits, each recipient whose family income exceeds 175 percent of the federal poverty income guidelines shall be required to pay an annual fee equal to the sum of:
(i)    5 percent of the amount by which the sum of the recipient’s adjusted gross income as defined in the Internal Revenue Code for federal income tax purposes plus Social Security benefits and tier 1 railroad retirement benefits not otherwise included in the recipient’s gross income under § 86 of the Internal Revenue Code exceeds 175 percent of the federal poverty guidelines adjusted for family size; and
(ii)    5 percent of the value of the recipient’s liquid assets above 200 percent of the federal poverty guidelines adjusted for family size.
(2)    The annual fee required under paragraph (1) of this subsection shall be collected quarterly by the Department.
(b)    A recipient is required to submit copies of the most recent tax returns of the recipient and of persons in the recipient’s family.
(c)    The Department shall provide recipients with a grace period after the deadline for a fee payment.
(d)    A recipient who has not paid overdue fees by the end of the grace period shall be terminated from the Program.
(e)    The Department shall extend the grace period in an appropriate hardship case.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-314 - Cost of Treatment -- Payments by State

(a)    This State shall pay the incurred cost of all treatment related to kidney disease that a certified patient is given, for any cause, on or after the date of certification of that patient, if the treatment is given in:
(1)    A certified dialysis or transplant center that is in this State;
(2)    A dialysis or transplant center that is in a contiguous state and is approved by that contiguous state and the Commission; or
(3)    A home dialysis program that is approved by the Commission.
(b)    The State shall pay the incurred cost of all approved hospital services provided in any Maryland hospital, other than routine chronic maintenance dialysis, which a certified patient may require as a direct result of end stage renal disease.
(c)    The State shall pay the incurred costs of all prescription drugs and other pharmaceutical products that are determined to be medically necessary by the recipient’s physician for treatment related to kidney disease in accordance with rates established by the Department.
(d)    The Secretary may not pay for any treatment that an individual receives at a facility or program that is not certified or otherwise approved.
(e)    (1)    Except for an invoice submitted to a Medicare intermediary or any other insurance provider, the Secretary may not make any payment for an invoice that the Secretary receives more than 6 months after the dates of the services given.
(2)    An invoice shall be submitted to the Secretary within 3 months after payment or rejection by the Medicare intermediary or other insurance providers.
(3)    A provider who fails to submit an invoice within the required time may not recover the amount later from either the patient or the Secretary.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 3 - Kidney Disease Program › Section 13-315 - Third Party Reimbursement

(a)    The Program shall be the payor of last resort. The Department is authorized to require providers to seek all available third party reimbursement prior to billing the Program.
(b)    If it is determined to be in the Department’s best interest, the Department may pay the health insurance premiums of recipients, including Part B premiums, to insurance carriers or employers under the Program.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 4 - Physical Fitness › Section 13-401 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “County advisory council” means an advisory council on physical fitness for a county.
(c)    “State Advisory Council” means the State Advisory Council on Health and Wellness.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 4 - Physical Fitness › Section 13-402 - Statement of Purpose

The purposes of this subtitle and of the advisory councils that it creates are to protect and improve physical fitness, including:
(1)    Improvement of habits in recreation, exercise, sports, and the use of leisure time;
(2)    Protection and improvement of physique and health; and
(3)    Improvement of instruction for any of these purposes.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 4 - Physical Fitness › Section 13-405 - Gifts, Grants, or Aid

If the federal government, any of its agencies or officers, or any other person offers to this State or to any county any services, equipment, supplies, materials, or funds by way of gift or grant for purposes of physical fitness, this State, acting in accordance with the requirements of law, may:
(1)    Accept the offer; and
(2)    Authorize any officer of this State or of a county to receive and use the aid and assistance.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 5 - Arthritis Prevention and Control Act › Section 13-502 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Advisory Council” means the State Advisory Council on Health and Wellness.
(c)    “Program” means the Arthritis Prevention and Control Program.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 5 - Arthritis Prevention and Control Act › Section 13-503 - Findings

The General Assembly finds that:
(1)    Arthritis encompasses more than 100 diseases and conditions that affect joints, the surrounding tissues, and other connective tissues;
(2)    As one of the most common family of diseases in the United States, arthritis affects nearly one of every six Americans and will impact an estimated 60,000,000 people by the year 2020;
(3)    Arthritis is the leading cause of disability in the United States, limiting daily activities for more than 7,000,000 people;
(4)    Although prevailing myths inaccurately portray arthritis as an old person’s disease, arthritis is a multigenerational disease that has become one of the country’s most pressing health problems;
(5)    Arthritis has a significant impact on quality of life for the individual experiencing the painful symptoms and for the family members and caregivers providing for that individual;
(6)    The economic and social costs associated with treating arthritis and the complications of arthritis are estimated at almost $80,000,000,000 annually;
(7)    Currently, the challenge exists to ensure delivery of effective, but often underutilized, interventions that are necessary in the prevention or reduction of arthritis-related pain and disability;
(8)    The large quantity of public information and programs about arthritis remain inadequately disseminated and are insufficient in addressing the needs of specific diverse populations and other underserved groups;
(9)    The Arthritis Foundation, the Centers for Disease Control and Prevention, and the Association of State and Territorial Health Officials have led the development of a public health strategy, the National Arthritis Action Plan, to ensure the delivery of effective, but often underutilized interventions that are necessary in the prevention or reduction of arthritis-related pain and disability; and
(10)    Educating the public and health care community throughout the State about arthritis is of paramount importance and is in every respect in the public interest and to the benefit of all residents of the State.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 5 - Arthritis Prevention and Control Act › Section 13-504 - Purpose of Subtitle

The purposes of this subtitle are to:
(1)    Create and foster a statewide program that promotes public awareness and increases knowledge about the causes of arthritis, the importance of early diagnosis and appropriate management, effective prevention strategies, and pain prevention and management;
(2)    Enhance understanding of arthritis by disseminating to patients, health professionals, and the public:
(i)    Educational materials;
(ii)    Information on research results;
(iii)    Information on services provided; and
(iv)    Strategies for prevention and control;
(3)    Establish a solid scientific base of knowledge on the prevention of arthritis and related disability through surveillance, epidemiology, and prevention research;
(4)    Utilize educational and training resources and services developed by organizations with appropriate expertise and knowledge of arthritis and use available technical assistance;
(5)    Evaluate the need for improving the quality and accessibility of existing community-based arthritis services;
(6)    Increase awareness about the prevention, detection, and treatment of arthritis among State and local health officials, providers, professionals, and policy makers;
(7)    Implement and coordinate State and local programs and services to reduce the public health burden of arthritis; and
(8)    Improve the quality of life and contain health care costs for individuals with arthritis and their families.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 5 - Arthritis Prevention and Control Act › Section 13-505 - Duties of Secretary

The Secretary shall:
(1)    Provide sufficient staff to implement the Program;
(2)    Provide appropriate training for staff of the Program;
(3)    Identify the appropriate organizations to carry out the Program;
(4)    Base the Program on the most current scientific information and findings;
(5)    Work to increase and improve community–based services available to people with arthritis and their family members;
(6)    Work with governmental offices, national voluntary health organizations and their local chapters, community and business leaders, community organizations, and health care and human service providers to coordinate efforts and maximize State resources in the areas of prevention, education, detection, pain management, and treatment of arthritis; and
(7)    Identify and, when appropriate, use evidence–based arthritis programs and obtain related materials and services from organizations with appropriate expertise and knowledge of arthritis.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 6 - Early Hearing Detection and Intervention Program › Section 13-601 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Hearing status” means the state of an individual’s ability to perceive sound, based on audiological assessment.
(c)    “Infant” means a child who is under the age of 1 year.
(d)    “Newborn” means a child up to 29 days old who is born in the State.
(e)    “Program” means the program that the Secretary establishes to provide for universal hearing screening of newborns and early identification and follow–up of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 6 - Early Hearing Detection and Intervention Program › Section 13-602 - Establishment of Program

(a)    The Secretary shall establish a program for the universal hearing screening of newborns and early identification and follow–up of newborns and infants who have, or who are at risk for developing, a permanent hearing status that affects speech–language skills.
(b)    The program shall be based on the model system developed by the Department.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 6 - Early Hearing Detection and Intervention Program › Section 13-603 - Early Hearing Detection and Intervention Advisory Council

(a)    There is an Early Hearing Detection and Intervention Advisory Council for the Program.
(b)    (1)    The Advisory Council consists of 12 members appointed by the Secretary.
(2)    Of the 12 members:
(i)    1 shall be a physician with expertise in childhood hearing status that affects speech–language skills;
(ii)    3 shall be from the field of education:
1.    1 shall be from the Maryland State Department of Education;
2.    1 shall be from the Maryland School for the Deaf; and
3.    1 shall be an educator of the deaf from a local education agency;
(iii)    1 shall be from the Maryland Department of Health;
(iv)    1 shall be a mental health professional with expertise in the area of deafness;
(v)    2 shall be parents of children with a permanent hearing status that affects speech–language skills;
(vi)    1 shall be from the Maryland Association of the Deaf;
(vii)    1 shall be an audiologist with expertise in childhood hearing status that affects speech–language skills;
(viii)    1 shall be from the Alexander Graham Bell Association of Maryland; and
(ix)    1 shall be from the Governor’s Office of the Deaf and Hard of Hearing.
(c)    (1)    The term of a member is 3 years.
(2)    The term of a member begins July 1.
(3)    The terms of members are staggered as required by the terms provided for members of the Advisory Council on July 1, 2014.
(4)    At the end of a term, a member continues to serve until a successor is appointed and qualifies.
(5)    A member who is appointed after a term has begun serves only for the rest of the term or until a successor is appointed and qualifies.
(6)    A member who serves 2 consecutive 3–year terms may not be reappointed for 3 years after completion of those terms.
(d)    The Advisory Council shall elect a chairperson from among its members.
(e)    The Advisory Council shall meet at least 4 times a year at the times and places that it determines.
(f)    A member of the Advisory Council:
(1)    May not receive compensation; but
(2)    Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(g)    The Advisory Council shall:
(1)    Advise the Department on the implementation of the Program;
(2)    Advise the Department on the development of protocols to assist hospitals, health care providers, and audiologists in conducting universal newborn hearing screening and follow–up hearing evaluations of infants;
(3)    Provide consultation to the Department in the establishment of an educational program for families, professionals, and the public that can be integrated with existing State and local education agency programs; and
(4)    Review any materials the Department may distribute to the public concerning the Program.
(h)    In consultation with the Advisory Council, the Department shall develop guidelines for the operations of the Advisory Council.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 6 - Early Hearing Detection and Intervention Program › Section 13-604 - Powers and Duties of Secretary

(a)    The Secretary may contract with any qualified person to administer the Program.
(b)    The Secretary shall:
(1)    Develop a system to gather and maintain data;
(2)    Develop methods to:
(i)    Contact parents or guardians of newborns and their identified primary care providers regarding the results of the newborn hearing screening;
(ii)    Contact parents or guardians of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills; and
(iii)    Ensure families are referred to appropriate services;
(3)    Establish a toll–free telephone line to communicate information about hearing status that affects speech–language skills and services for infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills;
(4)    Appoint an Advisory Council for the Program;
(5)    Meet annually with the Advisory Council; and
(6)    In consultation with the Advisory Council, adopt rules and regulations necessary to implement the Program.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 6 - Early Hearing Detection and Intervention Program › Section 13-605 - Results of Hearing Screening of Newborns to Be Included in Birth Event Information

(a)    As part of the supplemental information required to be submitted to the Department as part of the birth event, a hospital shall include the results of the hearing screening of the newborn.
(b)    The Department may adopt regulations for results reporting procedures for hospitals, birthing sites, and audiologists.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7 - Emergency and Allergy Treatment Program › Section 13-701 - Purpose

The Emergency and Allergy Treatment Program is a program in the Department for the purpose of providing a means of authorizing certain individuals to administer life–saving treatment to individuals who have severe adverse reactions to allergens or insect stings when physician, registered nurse practitioner, or emergency medical services are not immediately available in a youth camp.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7 - Emergency and Allergy Treatment Program › Section 13-702 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Agent” means an individual who:
(1)    Is at least 18 years of age;
(2)    Has successfully completed, at the expense of an applicant, an educational training program approved by the Department; and
(3)    Is appointed by a certificate holder to administer auto–injectable epinephrine in accordance with the provisions of this subtitle.
(c)    “Anaphylaxis” means a sudden, severe, and potentially life–threatening allergic reaction that occurs when an individual is exposed to an allergen.
(d)    “Auto–injectable epinephrine” means a portable, disposable drug delivery device that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.
(e)    “Certificate” means a certificate or an endorsement on the operating certificate of a youth camp issued by the Department to an individual who operates a youth camp under Title 14, Subtitle 4 of this article to obtain, store, and administer auto–injectable epinephrine.
(f)    “Certificate holder” means an individual who is authorized by the Department to obtain, store, and administer auto–injectable epinephrine to be used in an emergency situation.
(g)    “Program” means the Emergency and Allergy Treatment Program.
(h)    “Registered nurse practitioner” has the meaning stated in § 8–101 of the Health Occupations Article.
(i)    “Youth camp” has the meaning stated in § 14–401 of this article.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7 - Emergency and Allergy Treatment Program › Section 13-703 - Authority of Department

(a)    The Department may:
(1)    Adopt regulations for the administration of the Program;
(2)    Collect fees necessary for the administration of the Program;
(3)    Issue and renew a certificate to a person meeting the requirements of this subtitle; and
(4)    Approve educational training programs, including programs conducted by other State agencies or private entities.
(b)    A certificate issued by the Department shall be valid for up to 1 year.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7 - Emergency and Allergy Treatment Program › Section 13-704 - Qualifications

(a)    To qualify for a certificate, an individual shall meet the requirements of this section.
(b)    The applicant shall operate a youth camp.
(c)    The applicant shall be at least 18 years old.
(d)    The applicant shall successfully complete, at the expense of the applicant, an educational training program approved by the Department.
(e)    An applicant shall have a written policy that includes:
(1)    Authorization for the certificate holder or agent to administer auto–injectable epinephrine, if available, to an individual who has been determined to be or is believed to be experiencing anaphylaxis, whether or not the individual:
(i)    Has previously been known to have experienced anaphylaxis; or
(ii)    Has a prescription for epinephrine prescribed by an authorized health care practitioner licensed under the Health Occupations Article;
(2)    A requirement that youth camp personnel complete training on how to recognize the symptoms of anaphylaxis;
(3)    Procedures for the emergency administration of auto–injectable epinephrine;
(4)    Procedures for proper emergency follow–up;
(5)    Authorization for a certificate holder to obtain and store auto–injectable epinephrine to be used in an emergency; and
(6)    A requirement that each certificate holder implement a method for notifying the parent or guardian of a camper of the youth camp’s policy under this section before the camper’s attendance.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7 - Emergency and Allergy Treatment Program › Section 13-705 - Prescribing Auto-Injectable Epinephrine

(a)    (1)    A registered nurse practitioner or a physician licensed to practice medicine in the State may prescribe auto–injectable epinephrine in the name of a certificate holder.
(2)    A registered nurse practitioner, a pharmacist licensed to practice pharmacy in the State, or a physician may dispense auto–injectable epinephrine under a prescription issued to a certificate holder.
(b)    A certificate holder may:
(1)    On presentment of a certificate, receive from any registered nurse practitioner or any physician licensed to practice medicine in the State a prescription for auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine; and
(2)    Possess and store prescribed auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine.
(c)    In an emergency situation when registered nurse practitioner, physician, or emergency medical services are not immediately available, a certificate holder or agent may administer auto–injectable epinephrine to an individual who is experiencing or believed in good faith by the certificate holder or agent to be experiencing anaphylaxis.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7 - Emergency and Allergy Treatment Program › Section 13-706 - Reports

(a)    A certificate holder shall submit to the Department, on a form required by the Department, a report of each incident that occurs while the youth camp is in session that required the administration of auto–injectable epinephrine.
(b)    On or before January 31 of each year, the Department shall publish a report summarizing the information obtained from the reports submitted to the Department under subsection (a) of this section.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7 - Emergency and Allergy Treatment Program › Section 13-707 - Immunity From Liability -- Certified Individuals or Agents

(a)    A cause of action may not arise against a certificate holder or agent authorized under this subtitle for any act or omission when the certificate holder or agent is acting in good faith while administering auto–injectable epinephrine to an individual experiencing or believed by the certificate holder or agent to be experiencing anaphylaxis, except where the conduct of the certificate holder or agent amounts to gross negligence, willful or wanton misconduct, or intentionally tortious conduct.
(b)    (1)    A cause of action may not arise against any physician for any act or omission when the physician in good faith prescribes or dispenses auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine to a person certified by the Department under this subtitle.
(2)    A cause of action may not arise against any pharmacist for any act or omission when the pharmacist in good faith dispenses auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine to a person certified by the Department under this subtitle.
(3)    A cause of action may not arise against any nurse practitioner for any act or omission when the nurse practitioner in good faith prescribes or dispenses auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine to a person certified by the Department under this subtitle.
(c)    This section does not affect, and may not be construed as affecting, any immunities from civil liability or defenses established by any other provision of the Code or by common law to which a volunteer, registered nurse practitioner, physician, or pharmacist may be entitled.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7 - Emergency and Allergy Treatment Program › Section 13-708 - Immunity From Liability -- Uncertified Individuals

(a)    This subtitle may not be construed to create a duty upon any individual to obtain a certificate under this subtitle, and an individual may not be held civilly liable for failing to obtain a certificate under this subtitle.
(b)    An individual may not be held civilly liable in any action arising from or in connection with the administration of auto–injectable epinephrine by the individual solely because the individual did not possess a certificate issued under this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7A - Emergency Use Auto-Injectable Epinephrine Program › Section 13-7A-01 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Agent” means an individual who:
(1)    Is at least 18 years of age;
(2)    Has successfully completed, at the expense of the participating facility, an educational training program approved by the Department under § 13–7A–03 of this subtitle; and
(3)    Is designated by a certificate holder to administer auto–injectable epinephrine in accordance with the provisions of this subtitle.
(c)    “Anaphylaxis” means a sudden, severe, and potentially life–threatening allergic reaction that occurs when an individual is exposed to an allergen.
(d)    “Auto–injectable epinephrine” means a portable, disposable drug delivery device that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.
(e)    “Certificate” means a certificate issued by the Department to an individual to obtain, store, and administer auto–injectable epinephrine.
(f)    “Certificate holder” means an individual who is authorized by the Department to obtain, store, and administer auto–injectable epinephrine to be used in an emergency situation.
(g)    “Eligible institution” means an institution of higher education that has a food service facility or a recreation and wellness facility on the premises and that is authorized under this subtitle to obtain and store auto–injectable epinephrine.
(h)    “Food service facility” has the meaning indicated in § 21–301 of this article.
(i)    “Participating facility” means a recreation or wellness facility at an eligible institution or a food service facility, including a food service facility at an eligible institution, in the State that voluntarily participates in the Program.
(j)    “Program” means the Emergency Use Auto–Injectable Epinephrine Program established under § 13–7A–02 of this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7A - Emergency Use Auto-Injectable Epinephrine Program › Section 13-7A-02 - Emergency Use Auto-Injectable Epinephrine Program

(a)    There is an Emergency Use Auto–Injectable Epinephrine Program.
(b)    The purpose of the Program is to authorize individuals employed by a participating facility to obtain and store auto–injectable epinephrine and administer auto–injectable epinephrine to individuals who are experiencing or are believed to be experiencing anaphylaxis when a physician or emergency medical services are not immediately available.
(c)    (1)    Subject to paragraph (4) of this subsection, each participating facility may obtain:
(i)    A prescription for a supply of auto–injectable epinephrine from a licensed physician as provided in § 13–7A–06 of this subtitle; and
(ii)    A supply of auto–injectable epinephrine from a licensed pharmacist or a licensed physician as provided in § 13–7A–06 of this subtitle.
(2)    Each participating facility shall store a supply of auto–injectable epinephrine obtained under paragraph (1)(ii) of this subsection:
(i)    In accordance with the manufacturer’s instructions; and
(ii)    In a location that is readily accessible to employees or affiliated individuals in an emergency situation.
(3)    Each participating facility shall designate the employees who are certificate holders or designated affiliated individuals who are certificate holders who will be responsible for the storage, maintenance, and control of the supply of auto–injectable epinephrine.
(4)    A participating facility may not obtain or store auto–injectable epinephrine unless the participating facility has at least two employees or designated affiliated individuals who are certificate holders.
(5)    Each participating facility shall maintain a copy of the certificate issued to an employee or a designated affiliated individual under § 13–7A–05 of this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7A - Emergency Use Auto-Injectable Epinephrine Program › Section 13-7A-03 - Duties

(a)    The Department shall:
(1)    Adopt regulations for the administration of the Program;
(2)    Collect fees necessary for the administration of the Program;
(3)    Issue a certificate to, or renew the certificate of, an individual meeting the requirements of § 13–7A–04 of this subtitle;
(4)    Approve educational training programs, including programs conducted by other State agencies or private entities;
(5)    Develop a method by which certificate holders may submit a report to the Department about each incident that occurred on the premises of a participating facility that involved the administration of auto–injectable epinephrine by a certificate holder or an agent; and
(6)    On or before January 31 each year, publish a report summarizing the information obtained from reports submitted to the Department under item (5) of this subsection.
(b)    The Department may:
(1)    Set an application fee for a certificate;
(2)    Establish a fee for the renewal or replacement of a certificate; and
(3)    Require applicants to apply to the Program in the manner the Department chooses.
(c)    An educational training program approved by the Department under subsection (a)(4) of this section may be an online training program.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7A - Emergency Use Auto-Injectable Epinephrine Program › Section 13-7A-04 - Qualifications for Certificate

(a)    To qualify for a certificate, an applicant shall:
(1)    Be employed by a participating facility;
(2)    Successfully complete, at the expense of the participating facility, an educational training program approved by the Department under § 13–7A–03 of this subtitle;
(3)    Submit an application to the Department in a manner required by the Department under § 13–7A–03 of this subtitle; and
(4)    Subject to subsection (b) of this section, pay to the Department an application fee required under § 13–7A–03 of this subtitle.
(b)    (1)    A participating facility may pay the application fee on behalf of the applicant.
(2)    If the participating facility is a food service facility that is part of an eligible institution, either entity may pay the application fee on behalf of the applicant.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 7A - Emergency Use Auto-Injectable Epinephrine Program › Section 13-7A-05 - Certificate

(a)    The Department shall issue a certificate to any applicant who meets the requirements of § 13–7A–04 of this subtitle.
(b)    Each certificate shall include:
(1)    The full name of the certificate holder; and
(2)    A serial number.
(c)    A replacement certificate may be issued to replace a lost, destroyed, or mutilated certificate if the certificate holder pays a certificate replacement fee set by the Department.
(d)    (1)    A certificate shall be valid for a term of 1 year.
(2)    To renew a certificate for an additional 1–year term, the renewal applicant shall successfully complete a refresher educational training program approved by the Department under § 13–7A–03 of this subtitle.